[go: up one dir, main page]

BR0010449A - 14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs - Google Patents

14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs

Info

Publication number
BR0010449A
BR0010449A BR0010449-3A BR0010449A BR0010449A BR 0010449 A BR0010449 A BR 0010449A BR 0010449 A BR0010449 A BR 0010449A BR 0010449 A BR0010449 A BR 0010449A
Authority
BR
Brazil
Prior art keywords
14beta
sterols
preparation
pharmaceutical compositions
derivatives
Prior art date
Application number
BR0010449-3A
Other languages
Portuguese (pt)
Inventor
Peter Esperling
Joachim Kuhnke
Henry Laurent
Thorsten Blume
Christa Hegele-Hartung
Monika Lessl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0010449A publication Critical patent/BR0010449A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "14BETA-H-ESTERóIS, COMPOSIçõES FARMACêUTICAS QUE COMPREENDEM OS MESMOS E USO DESTES DERIVADOS PARA A PREPARAçãO DE MEDICAMENTOS REGULADORES DA MEIOSE". A presente invenção refere-se a 14beta-H-esteróis, farmaceuticamente ativos, a composições farmacêuticas que compreendem as mesmas e ao uso destes novos compostos para a preparação de medicamentos. Mais particularmente foi descoberto que os 14beta-H-esteróis da invenção podem ser usados para regular a meiose.Invention Patent: "14BETA-H-STEROLS, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THE SAME AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATORY DRUGS". The present invention relates to 14beta-H-sterols, pharmaceutically active, to pharmaceutical compositions comprising them and to the use of these new compounds for the preparation of medicaments. More particularly it has been found that the 14beta-H-sterols of the invention can be used to regulate meiosis.

BR0010449-3A 1999-05-10 2000-05-05 14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs BR0010449A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99250153 1999-05-10
PCT/EP2000/004092 WO2000068245A1 (en) 1999-05-10 2000-05-05 14β-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS

Publications (1)

Publication Number Publication Date
BR0010449A true BR0010449A (en) 2002-02-13

Family

ID=8241145

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010449-3A BR0010449A (en) 1999-05-10 2000-05-05 14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs

Country Status (18)

Country Link
EP (1) EP1177205A1 (en)
JP (1) JP2002544136A (en)
KR (1) KR20020013541A (en)
CN (1) CN1350543A (en)
AU (1) AU4756100A (en)
BG (1) BG106093A (en)
BR (1) BR0010449A (en)
CA (1) CA2373442A1 (en)
CZ (1) CZ20013981A3 (en)
EA (1) EA200101157A1 (en)
EE (1) EE200100592A (en)
HU (1) HUP0201098A2 (en)
IL (1) IL145373A0 (en)
NO (1) NO20015488L (en)
PL (1) PL352029A1 (en)
SK (1) SK16212001A3 (en)
WO (1) WO2000068245A1 (en)
ZA (1) ZA200110073B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9376462B2 (en) * 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
CN112334476B (en) * 2019-09-09 2022-03-15 邦泰生物工程(深圳)有限公司 A kind of method of synthesizing chenodeoxycholic acid and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
AU717180B2 (en) * 1995-03-06 2000-03-16 Novo Nordisk A/S Stimulation of meiosis
ATE256144T1 (en) * 1998-05-13 2003-12-15 Novo Nordisk As USE OF COMPOUNDS WITH THE ABILITY TO REGULATE MEIOSIS

Also Published As

Publication number Publication date
EP1177205A1 (en) 2002-02-06
CN1350543A (en) 2002-05-22
HUP0201098A2 (en) 2002-08-28
WO2000068245A1 (en) 2000-11-16
EA200101157A1 (en) 2002-06-27
CA2373442A1 (en) 2000-11-16
JP2002544136A (en) 2002-12-24
SK16212001A3 (en) 2002-02-05
EE200100592A (en) 2003-02-17
NO20015488D0 (en) 2001-11-09
PL352029A1 (en) 2003-07-28
ZA200110073B (en) 2003-03-06
CZ20013981A3 (en) 2002-02-13
BG106093A (en) 2002-05-31
NO20015488L (en) 2002-01-09
AU4756100A (en) 2000-11-21
IL145373A0 (en) 2002-06-30
KR20020013541A (en) 2002-02-20

Similar Documents

Publication Publication Date Title
BR9508287A (en) Formulation for inhalation application
BR9807974A (en) Pharmaceutical composition for prolonged release of an erythromycin derivative in the gastrointestinal environment, and process for using the same
DE69940557D1 (en) A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER
BR0009437A (en) Pre-gelatinized starch in a controlled release formulation
AR006678A1 (en) DERIVATIVES OF TRICYCLIC MACROLIDES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THEM TO PREPARE MEDICINES AND PROCEDURE FOR THEIR PREPARATION
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
UA41346C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING FLUOXETIN OR ITS SALTS, TABLE BASED ON ITS, METHOD OF MANUFACTURE OF DISPERSING TABLET
NO330947B1 (en) The use of oxcarbazepine-containing pharmaceutical compositions in the fasted state
AR007040A1 (en) Erythromycin 6-0-SUBSTITUTED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USE OF SUCH COMPOUNDS TO PREPARE MEDICINES AND PROCEDURE FOR SUPREPARATION
ES2061252T3 (en) ANTITUSIVE AGENT AND REGULATOR OF THE MUCOSA, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
AR020001A1 (en) ACTIVATING COMPOUNDS OF hPPARGAMMA AND hPPARALFA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD FOR THE TREATMENT AND / OR PREVENTION OF A DISEASE MEDIATED BY THE SAME, AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
BRPI0518266A2 (en) modified-release oral medicinal product of at least one active ingredient in multi-capsule form
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
BR0211198A (en) Pharmaceutical compositions and their use
BR0209283A (en) Method for the manufacture of a low dosage pharmaceutical composition having uniform drug distribution and potency
SE9901573D0 (en) New compounds
BR9809268A (en) Pharmaceutical dosage unit, process for manufacturing it, and use of a starch product as a carrier for pharmaceutical dosage units comprising tibolone
KR970032872A (en) Drugs for the treatment of skin damage containing acetylsalicylic acid
BR0111051A (en) Pharmaceutical product and daily pharmaceutical dose for administration to a patient, dose regimen providing an anti-androgenic effect and an antiestrogenic effect on a patient, use of a compound and tamoxifen or a pharmaceutically acceptable salt or solvate thereof, and, method for providing an anti-androgenic effect in a patient
AR035006A1 (en) DERIVATIVE OF NAFTIRIDIN-DIBENZO [A, D] CICLOHEPTENO-10-ACETICO, PHARMACEUTICAL COMPOSITION, AND THE USE OF THAT DERIVATIVE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
SE9901572D0 (en) New compounds
BR0010449A (en) 14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs
ATE236885T1 (en) HYDRAZONO-BENZAZULENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE PRODUCTS
SE9902936D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]